APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS Kim, W. R., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S., Janssen, H. A., Lampertico, P., Lau, D., Bornstein, J. D., Schall, R. A., Dinh, P., Yee, L. J., Martins, E. B., Lim, S. G., Loomba, R., Petersen, J., Buti, M., Marcellin, P. ELSEVIER SCIENCE BV. 2014: S288–S289

View details for DOI 10.1016/S0168-8278(14)60823-0

View details for Web of Science ID 000362828600079